Have a personal or library account? Click to login
Status of rats myocardium under subchronic mercury exposure and its pharmacological correction Cover

Status of rats myocardium under subchronic mercury exposure and its pharmacological correction

Open Access
|Jan 2017

References

  1. 1. Aaseth J. et al.: Chelation in metal intoxication-Principles and paradigms. J Trace Elem Med Biol., 31, 260-266, 2015.10.1016/j.jtemb.2014.10.00125457281
  2. 2. Avtandilov G.G. (1990): Medical morphometry. Guide. Medicine. (in Russian)
  3. 3. Ballmann C. et al.: Histological and biochemical outcomes of cardiac pathology in mdx mice with dietary quercetin enrichment. Exp Physiol, 100, 12-22, 2015.10.1113/expphysiol.2014.08336025557727
  4. 4. Bernhoft R.A.: Mercury toxicity and treatment: a review of the literature. J Environ Public Health,. 2012, 2012.10.1155/2012/460508325345622235210
  5. 5. Busch J. et al.: The heavy metals cadmium, lead and mercury in raw materials of animal origin: evaluation of data from practice. Pharm Bio Sci Notes, 2015, 150-165, 2015.
  6. 6. Cao Y. et al.: Chelation therapy in intoxications with mercury, lead and copper. J Trace Elem Med Biol., 31, 188-192, 2015.10.1016/j.jtemb.2014.04.01024894443
  7. 7. Dziegiel P. et al.: Metallothioneins: Structure and Functions. Adv Anat Embryol Cell Biol, 218, 1-117, 2016.
  8. 8. Figueredo F.G. et al.: Cytoprotective Effect of Lygodium venustum Sw. (Lygodiaceae) against Mercurium Chloride Toxicity. Scientifica (Cairo). 2016, 4154265, 2016.10.1155/2016/4154265478951527034899
  9. 9. Foras L.D.: Quercetin in treatment cardiovascular. The radical Research., 39, 2005.
  10. 10. Graham I. et al.: Fourth joint task force of European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil., 14, 2, S1-113, 2007.
  11. 11. Jain A.K., Mehra N.K., Swarnakar N.K.: Role of Antioxidants for the Treatment of Cardiovascular Diseases: Challenges and Opportunities. Curr Pharm Des., 21(30), 4441-4455, 2015.10.2174/138161282166615080315175826234792
  12. 12. Kaminsky R. et al.: A study of impact of mercury chloride on myocardium in experiment. Georgian Med News., 251, 64-70, 2016.
  13. 13. Kim K.H. et al.: A review on the distribution of Hg in the environment and its human health impacts. J Hazard Mater, 306, 376-385, 2016.10.1016/j.jhazmat.2015.11.03126826963
  14. 14. Pierce E. (1962). Histochemistry theoretical and applied. M Moscow: Univ. foreign. Literature.
  15. 15. Rafati-Rahimzadeh M. et al.: Current approaches of the management of mercury poisoning: need of the hour. Daru, 22, 46, 2014.10.1186/2008-2231-22-46405590624888360
  16. 16. Sokurenko L.M. et al.: Mildronate protects neuroblasts against toxic influence of mercuric chloride in cell culture. Neurophysiology, 46(3), 271-273, 2014.10.1007/s11062-014-9440-7
DOI: https://doi.org/10.1515/cipms-2016-0035 | Journal eISSN: 2300-6676 | Journal ISSN: 2084-980X
Language: English
Page range: 167 - 170
Submitted on: Jun 28, 2016
|
Accepted on: Jul 29, 2016
|
Published on: Jan 23, 2017
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2017 Kaminsky F. Rostislav, Sokurenko M. Liudmyla, Chaikovsky B. Yuri, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.